Leuprolide acetate and Non-hodgkin's lymphoma - a phase IV clinical study of FDA data

Summary:

Non-hodgkin's lymphoma is reported only by a few people who take Leuprolide Acetate.

The phase IV clinical study analyzes which people take Leuprolide acetate and have Non-hodgkin's lymphoma. It is created by eHealthMe based on reports of 4,718 people who have side effects while taking Leuprolide acetate from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

4,718 people reported to have side effects when taking Leuprolide acetate.
Among them, 2 people (0.04%) have Non-hodgkin's lymphoma.


What is Leuprolide acetate?

Leuprolide acetate has active ingredients of leuprolide acetate. eHealthMe is studying from 4,745 Leuprolide acetate users for its effectiveness, alternative drugs and more.

What is Non-hodgkin's lymphoma?

Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system) is found to be associated with 1,545 drugs and 1,176 conditions by eHealthMe.

Number of Leuprolide acetate and Non-hodgkin's lymphoma reports submitted per year:

Could Leuprolide acetate cause Non-hodgkin's lymphoma?

Time on Leuprolide acetate when people have Non-hodgkin's lymphoma *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Non-hodgkin's lymphoma when taking Leuprolide acetate *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Non-hodgkin's lymphoma when taking Leuprolide acetate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Leuprolide acetate *:

  1. Norvasc: 1 person, 50.00%
  2. Casodex: 1 person, 50.00%
  3. Blopress: 1 person, 50.00%
  4. Aspirin: 1 person, 50.00%
  5. Amlodipine: 1 person, 50.00%
  6. Actos: 1 person, 50.00%

Common side effects people have besides Non-hodgkin's lymphoma *:

  1. Swelling Face: 1 person, 50.00%
  2. Injection Site Induration: 1 person, 50.00%

Common conditions people have *:

  1. Prostate Cancer Stage Ii: 1 person, 50.00%
  2. Prostate Cancer: 1 person, 50.00%
  3. High Blood Pressure: 1 person, 50.00%
  4. Heart Attack: 1 person, 50.00%
  5. Diabetes: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Leuprolide acetate and have Non-hodgkin's lymphoma?

Check whether Non-hodgkin's lymphoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Non-hodgkin's lymphoma and when was it recovered:

Expand to all the drugs that have ingredients of leuprolide acetate:

Alternative drugs to, pros and cons of Leuprolide acetate:

Common Leuprolide acetate side effects:

Browse all side effects of Leuprolide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Non-hodgkin's lymphoma treatments and more:

COVID vaccines that are related to Non-hodgkin's lymphoma:

Common drugs associated with Non-hodgkin's lymphoma:

All the drugs that are associated with Non-hodgkin's lymphoma:

Common conditions associated with Non-hodgkin's lymphoma:

All the conditions that are associated with Non-hodgkin's lymphoma:

How the study uses the data?

The study uses data from the FDA. It is based on leuprolide acetate (the active ingredients of Leuprolide acetate) and Leuprolide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: